001431722 000__ 06354cam\a2200637\a\4500
001431722 001__ 1431722
001431722 003__ OCoLC
001431722 005__ 20230309003238.0
001431722 006__ m\\\\\o\\d\\\\\\\\
001431722 007__ cr\un\nnnunnun
001431722 008__ 200810s2021\\\\sz\\\\\\o\\\\\001\0\eng\d
001431722 019__ $$a1182867677$$a1191066827$$a1197561803$$a1198133290$$a1198817561$$a1204083990
001431722 020__ $$a9783030459239$$q(electronic bk.)
001431722 020__ $$a3030459233$$q(electronic bk.)
001431722 020__ $$z3030459225
001431722 020__ $$z9783030459222
001431722 0247_ $$a10.1007/978-3-030-45923-9.$$2doi
001431722 0248_ $$a10.1007/978-3-030-45
001431722 035__ $$aSP(OCoLC)1182844346
001431722 040__ $$aYDX$$beng$$epn$$cYDX$$dGW5XE$$dEBLCP$$dLQU$$dTEF$$dOCLCF$$dERF$$dUKMGB$$dN$T$$dOCLCO$$dCOM$$dOCLCQ
001431722 049__ $$aISEA
001431722 050_4 $$aRB147
001431722 08204 $$a616.3/9$$223
001431722 24500 $$aEndocrine disrupting chemicals-induced metabolic disorders and treatment strategies /$$cMuhammad Sajid Hamid, Akash Kanwal Rehman, Muhammad Zaffar Hashmi, editors.
001431722 260__ $$aCham, Switzerland :$$bSpringer,$$c[2021]
001431722 300__ $$a1 online resource
001431722 336__ $$atext$$btxt$$2rdacontent
001431722 337__ $$acomputer$$bc$$2rdamedia
001431722 338__ $$aonline resource$$bcr$$2rdacarrier
001431722 4901_ $$aEmerging Contaminants and Associated Treatment Technologies Ser.
001431722 500__ $$aIncludes index.
001431722 5050_ $$aIntro -- Foreword -- Foreword -- Endocrine Disrupting Chemicals-Induced Metabolic Disorders -- Preface -- Acknowledgement -- Contents -- Contributors -- Part I: Introduction to Endocrine System and Metabolic Disorders -- Chapter 1: Physiology of Endocrine System and Related Metabolic Disorders -- Introduction -- Endocrine Glands and Respective Hormones -- Pituitary Gland -- Anterior Pituitary Gland's Hormones -- Growth Hormone -- Prolactin -- Thyroid Stimulating Hormone (TSH) -- Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH) -- Adrenocorticotropic Hormone (ACTH)
001431722 5058_ $$aPosterior Pituitary Gland's Hormones -- Antidiuretic Hormone (ADH) -- Oxytocin -- Thyroid Gland -- T3 and T4 -- Calcitonin -- Control System for Thyroid Hormone Secretion -- Parathyroid Gland -- Parathyroid Hormone (PTH) -- Adrenal Gland -- Adrenal Medulla -- Catecholamines -- Adrenal Cortex -- Glucocorticoids -- Mineralocorticoids -- Pineal Gland -- The Gonads -- Estrogens -- Progestogens -- Androgen -- Pancreas -- Insulin -- Glucagon -- Metabolic Disorders -- Thyroid Gland Related -- Hyperthyroidism -- Signs and Symptoms -- Hypothyroidism -- Signs and Symptoms -- Iodine Deficiency
001431722 5058_ $$aParathyroid Gland Related Disorders -- Hypoparathyroidism -- Signs and Symptoms -- Adrenal Gland Related Disorders -- Acute Adrenal Insufficiency -- Signs and Symptoms -- Chronic Adrenal Insufficiency -- Signs and Symptoms -- Hyperadrenalism (Cushing's Syndrome) -- Signs and Symptoms -- Pituitary Gland Related Disorders -- Acromegaly -- Hyperprolactinemia or Galactorrhea -- Signs and Symptoms -- Erectile Dysfunction (ED) or Impotence -- Signs and Symptoms -- Central Diabetes Insipidus -- Primary Central Diabetes Insipidus -- Secondary Central Diabetes Insipidus -- Signs and Symptoms
001431722 5058_ $$aHypopituitarism -- Signs and Symptoms -- Growth Hormone Deficiency -- Hypothalamus Deficiencies -- Prolactin Deficiency -- Deficiency of Gonadotropins (FSH and LH) -- Pituitary Apoplexy -- Pancreas Related Disorders -- Diabetes Mellitus -- Signs and Symptoms -- Hypoglycemia -- Signs and Symptoms -- Diabetic Ketoacidosis -- Signs and Symptoms -- Hyperosmolar Hyperglycemic Nonketotic Coma -- Conclusion -- References -- Chapter 2: Impaired Carbohydrate Metabolism in Metabolic Disorders -- Introduction -- Metabolic Disorders Induced by Impaired Galactose Metabolism -- Classic Galactosemia
001431722 5058_ $$aGALE Deficiency Galactosemia -- Cataracts -- Metabolic Disorders Induced by Impaired Fructose Metabolism -- Essential Fructosuria -- Hereditary Fructose Intolerance -- Fructose-1,6-Phosphatase Deficiency -- Metabolic Disorders Induced by Impaired Glycogen Metabolism -- Glycogen Storage Diseases -- GSD Type 0 -- GSD Type I -- GSD Type II -- GSD Type III -- GSD Type IV -- GSD Type V -- GSD Type VI -- GSD Type VII -- GSD Type VIII -- GSD Type IX -- Conclusion -- References -- Chapter 3: Mitochondrial Dysfunction in Metabolic Disorders -- Introduction -- Functional and Dysfunctional Mitochondria
001431722 506__ $$aAccess limited to authorized users.
001431722 520__ $$aThis volume offers a detailed and comprehensive analysis of Endocrine Disrupting Chemicals (EDCs), covering their occurrence, exposure to humans and the mechanisms that lead to the parthogenesis of EDCs-induced metabolic disorders. The book is divided into three parts. Part I describes the physiology of the human endocrine system, with special emphasis on various types of metabolic disorders along with risk factors that are responsible for the development of these disorders. Part II addresses all aspects of EDCs, including their role in the induction of various risk factors that are responsible for the development of metabolic disorders. Part III covers up-to-date environmental regulatory considerations and treatment strategies that have been adopted to cure and prevent EDCs-induced metabolic disorders. This section will primarily appeal to clinicians investigating the causes and treatment of metabolic disorders. The text will also be of interest to students and researchers in the fields of Environmental Pharmacology and Toxicology, Environmental Pollution, Pharmaceutical Biochemistry, Biotechnology, and Drug Metabolism/Pharmacokinetics.
001431722 650_0 $$aMetabolism$$xDisorders.
001431722 650_0 $$aMetabolism$$xDisorders$$xTreatment.
001431722 650_0 $$aEndocrine disrupting chemicals.
001431722 650_6 $$aTroubles du métabolisme.
001431722 650_6 $$aTroubles du métabolisme$$xTraitement.
001431722 650_6 $$aPerturbateurs endocriniens.
001431722 655_0 $$aElectronic books.
001431722 7001_ $$aHamid, Muhammad Sajid.
001431722 7001_ $$aRehman, Akash Kanwai.
001431722 7001_ $$aHashmi, Muhammad Zaffar.
001431722 77608 $$iPrint version:$$z3030459225$$z9783030459222$$w(OCoLC)1144894041
001431722 830_0 $$aEmerging Contaminants and Associated Treatment Technologies Ser.
001431722 852__ $$bebk
001431722 85640 $$3Springer Nature$$uhttps://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-3-030-45923-9$$zOnline Access$$91397441.1
001431722 909CO $$ooai:library.usi.edu:1431722$$pGLOBAL_SET
001431722 980__ $$aBIB
001431722 980__ $$aEBOOK
001431722 982__ $$aEbook
001431722 983__ $$aOnline
001431722 994__ $$a92$$bISE